Sun Pharma Q2 net profit rises 5% to Rs 2,375 crore

Sun Pharmaceutical Industries Ltd. reported second-quarter consolidated net profit grew 5% to Rs 2,375.5 crore from the year-earlier period.  Gross sales at Rs 12,003 crore, grew 11.0% Year on Year (YoY). India formulation sales at Rs 38,42.5 crore, grew 11.1% YoY while U.S. formulation sales increased 4.2% YoY to $430 million.

The company said it’s global specialty sales increased 19.3% YoY to $240 million and  global specialty sales accounted for 16.4% of Q2FY24 sales.

Emerging Markets formulation sales at $284 million, grew 9.4% YoY and Rest of World formulation sales increased 13.7% YoY to $206 million, the company said in a filing.

Dilip Shanghvi, Managing Director in a statement said, “U.S. FDA’s acceptance of deuruxolitinib NDA for treatment of moderate to severe alopecia areata marks an important milestone.

“There are limited treatment options for alopecia areata and deuruxolitinib should make a meaningful difference in patient lives, once approved,” he said.

“Similarly, another late stage candidate Nidlegy will potentially complement our Odomzo franchise. Nidlegy’s recent positive phase-3 data in patients with locally advanced fully resectable melanoma positions us to provide patient solutions across a broad spectrum of skin cancers,” he added.

Related Posts

  • Pharma
  • July 24, 2025
  • 224 views
Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

  • Pharma
  • July 22, 2025
  • 301 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra